Orexigen Surges – Even if Regulators Aren’t Happy About It


Orexigen Therapeutics Inc. (NASDAQ:OREX), Intrexon Corp. (NYSE:XON) and Voltari Corp. (NASDAQ:VLTC) ended the day well in the green this Tuesday. Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC), Solazyme Inc. (NASDAQ:SZYM) and Allied Nevada Gold Corp. (NYSEMKT:ANV), on the other hand, hit market close in the red.

Sign up for our free newsletter

Orexigen Rallies

Orexigen Therapeutics Inc. soared +31.95% after the drug maker said its diet pill has cardiovascular benefits. Regulators criticized the firm for releasing the data; however, investors seem not to be concerned. Farallon Capital has a stake in the biotech company.


Intrexon surged +19.72%, ending the day priced at $48.15. The stock, a Dan Loeb pick, has climbed nearly +75% year-to-date.

Carl Icahn investment Voltari Corp. rallied +14.4% to $0.94 this Tuesday and is up +43.88% for the year. It’s still trading far away from its 52-week high of $3.96.

Cyclacel Pharmaceuticals Plunges

Cyclacel Pharmaceuticals plunged -15.98%, ending the day at $1.42. Despite today’s dip, it’s up +147.47% over the past month. Billionaire Wilbur Ross has a small stake in the firm.

Solazyme Inc. tumbled -7.46% today. A maker of renewable oils and other bioproducts, the company recently won IP arbitration over a failed joint venture – news that broke yesterday. Chase Coleman’s Tiger Global has a 0.02% allocation in the company.

The share price of Allied Nevada Gold Corp. fell -7.29% to $0.86 – just cents away from its 52-week low of $0.72. John Paulson has a position in the firm.

Screen Shot 2015-02-23 at 3.00.26 PM


For exclusive info on hedge funds and the latest news from value investing world at only a few dollars a month check out ValueWalk Premium right here.

Multiple people interested? Check out our new corporate plan right here (We are currently offering a major discount)

About the Author

iBillionaire provides access to the investment data and strategies of the world's most successful self-made billionaires. Mobile app available for iOS and Android. Maker of the iBillionaire Index (IBLN). More at www.iBillionaire.me.

Be the first to comment on "Orexigen Surges – Even if Regulators Aren’t Happy About It"

Leave a comment